Mycept 250 mg Capsule Philippines - English - FDA (Food And Drug Administration)

mycept 250 mg capsule

n/a; importer: dega international pharma corp.; distributor: dega international pharma corp. - mycophenolate mofetil - capsule - 250 mg

SPAN-K 600mg Sustained-Release Tablet Philippines - English - FDA (Food And Drug Administration)

span-k 600mg sustained-release tablet

aspen pharmacare australia pty limited - australia; importer: dega international pharma corporation; distributor: dega international pharma corporation - potassium chloride - sustained-release tablet - 600mg

FIRMAGON POWDER FOR SOLUTION Canada - English - Health Canada

firmagon powder for solution

ferring inc - degarelix (degarelix acetate) - powder for solution - 80mg - degarelix (degarelix acetate) 80mg - antineoplastic agents

FIRMAGON POWDER FOR SOLUTION Canada - English - Health Canada

firmagon powder for solution

ferring inc - degarelix (degarelix acetate) - powder for solution - 120mg - degarelix (degarelix acetate) 120mg - antineoplastic agents

Firmagon European Union - English - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degarelix - prostatic neoplasms - endocrine therapy - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer.- for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.- as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

FIRMAGON degarelix (as acetate) composite pack of 80mg powder in vial and solvent for injection in pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

firmagon degarelix (as acetate) composite pack of 80mg powder in vial and solvent for injection in pre-filled syringe

ferring pharmaceuticals pty ltd - water for injections, quantity: 4.2 ml - injection - excipient ingredients: - firmagon is a gnrh receptor blocker indicated for treatment of patients with prostate cancer in whom androgen deprivation is warranted.

FIRMAGON degarelix (as acetate) composite 120 mg powder in vial and solvent for injection in pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

firmagon degarelix (as acetate) composite 120 mg powder in vial and solvent for injection in pre-filled syringe

ferring pharmaceuticals pty ltd - water for injections, quantity: 3 ml - injection - excipient ingredients: - firmagon is a gnrh receptor blocker indicated for treatment of patients with prostate cancer in whom androgen deprivation is warranted.

FIRMAGON 80 MG. POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE, S.C. Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

firmagon 80 mg. polvo y disolvente para solución inyectable, s.c.

ferring gmbh - degarelix (acetato) - degarelix (acetato) ....80 mg. / agua para inyectables (disolvente) c.s.p....4.2 ml.